From the

University of Alabama takes a Dogged Approach to Precision Medicine

Learn how the University of Alabama is taking a dogged approach to studying new brain tumor therapies.

PierianDx Forms Strategic Partnership with Leading Research and Technical Services Organization RTI International

PierianDx, the leading genomics technology companythat enables precision medicine,announced today a strategic partnership with RTI International to help solve the problem of translating complex genomic data into actionable clinical insight to […]

Optimizing the Bioinformatics Output of your Molecular Pathology Lab

We have a lot to gain from accelerating the adoption of NGS testing. The technology exists, but that’s only half the battle. The right approach matters too. Learn more by attending our informative webinar on April 24.

PierianDx Showcases Germline Capabilities of its Clinical Genomics WorkSpace™ (CGW) Platform at ACMG 2018

PierianDx, the leading genomics technology company that enables precision medicine, announced today at the annual meeting of the American College of Medical Genetics and Genomics (ACMG)  a series of enhanced germline […]

PierianDx Names Chris Callahan as Chief Commercial Officer to Drive Expansion of its Genomics Technology Platform for Clinical Labs

PierianDx named Chris Callahan as the new Chief Commercial Officer to accelerate adoption and expansion of the company’s enterprise informatics software platform, the Clinical Genomics WorkSpace (CGW). Chris will report […]

Cardiology Field Whole-heartedly Ready for Precision Medicine

Learn how cardiologists are bringing precision medicine to their patients.

PierianDx Announces TriCore Reference Laboratories as the Newest Customer to its Partner Sharing Network

Learn how TriCore Reference Laboratories will use the Clinical Genomics WorkSpace (CGW) from PierianDx to accelerate NGS testing.

All of Us Initiative: Highlighting the Need for Streamlined Genetic Analysis

Learn more about All of Us, the landmark study being launched by the NIH, and why we need solutions for streamlining genetic analysis.

Inova Launches Predictive Phenotyping Study with NIH

Learn more about the predictive phenotyping study being launched by Inova and the NIH.

PierianDx to Unveil Blueprint for Bringing Next Generation Sequencing (NGS) Testing In-house at Executive War College

The drive to deliver precision medicine has galvanized many hospitals to in-source next generation sequencing (NGS) testing. Working with our customers, we’ve established some best practices and will discuss them at the upcoming Executive War College.